Found 5 matching trials
Predictive Value of FMISO-PET, FDG-PET-CT, DWI-MRI and DCE-MRI Scans for Patients With Anal Cancer Receiving Radiotherapy +/- Chemotherapy N/A The purpose of the study is to evaluate the predictive value of 18F-fluorom...
Show More Location
Department of Oncology Herlev Hospital
Learn More & Join Trial
Positron Emission Tomography/Computed Tomography Scanning Before Surgery in Patients With Non-Small Cell Lung Cancer, Colorectal Cancer, Breast Cancer, Esophageal Cancer, or Head and Neck Cancer NA RATIONALE: Diagnostic procedures, such as positron emission tomography/comp...
Show More Location
University College Hospital
Learn More & Join Trial
Assessment of Primary and Metastatic Brain Tumor Hypoxia With Fluoromisonidazole, FDG and Water PHASE1 Purpose of Study This exploratory clinical study will investigate FMISO (fl...
Show More Location
Huntsman Cancer Institute
Learn More & Join Trial
Positron Emission Tomography and Computed Tomography in Guiding Radiation Therapy for Stage III Non-small Cell Lung Cancer PHASE2 This randomized phase II trial studies how well positron emission tomograph...
Show More Location
Stanford Cancer Institute Palo Alto
Learn More & Join Trial
18F-Fluoromisonidazole and Fludeoxyglucose F 18 PET/CT Patients With Soft Tissue Sarcoma PHASE2 This phase II trial is studying 18F-fluoromisonidazole and fludeoxyglucose ...
Show More Location
Seattle Cancer Care Alliance
Learn More & Join Trial